GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CureVac NV (LTS:0A9E) » Definitions » Other Long Term Assets

CureVac NV (LTS:0A9E) Other Long Term Assets : $8.1 Mil (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is CureVac NV Other Long Term Assets?

CureVac NV's other long-term assets for the quarter that ended in Mar. 2025 was $8.1 Mil.

CureVac NV's quarterly other long-term assets increased from Sep. 2024 ($2.0 Mil) to Dec. 2024 ($6.9 Mil) and increased from Dec. 2024 ($6.9 Mil) to Mar. 2025 ($8.1 Mil).

CureVac NV's annual other long-term assets increased from Dec. 2022 ($3.1 Mil) to Dec. 2023 ($3.2 Mil) and increased from Dec. 2023 ($3.2 Mil) to Dec. 2024 ($6.9 Mil).

CureVac NV Other Long Term Assets Historical Data

The historical data trend for CureVac NV's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CureVac NV Other Long Term Assets Chart

CureVac NV Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Long Term Assets
Get a 7-Day Free Trial 3.12 5.19 3.14 3.16 6.92

CureVac NV Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.39 2.34 1.98 6.92 8.06

CureVac NV Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

CureVac NV Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CureVac NV (LTS:0A9E) » Definitions » Other Long Term Assets
Comparable Companies
PRAX IMNM NUVB LENZ AVBP XNCR REPL DNTH ABCL QURE VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
CVAC:USA 1CVAC:Italy 5CV:Germany CVAC:Austria
Address
Friedrich-Miescher-Strasse 15, Tubingen, BW, DEU, 72076
Website
https://www.curevac.com
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

CureVac NV Headlines

No Headlines